Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-044411
Filing Date
2024-10-31
Accepted
2024-10-31 07:12:32
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cccc-20240930.htm   iXBRL 10-Q 1505477
2 EX-31.1 cccc-20240930xexx311.htm EX-31.1 10371
3 EX-31.2 cccc-20240930xexx312.htm EX-31.2 10417
4 EX-32.1 cccc-20240930xexx321.htm EX-32.1 4752
5 EX-32.2 cccc-20240930xexx322.htm EX-32.2 4763
  Complete submission text file 0001628280-24-044411.txt   6389876

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20240930.xsd EX-101.SCH 42270
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cccc-20240930_cal.xml EX-101.CAL 66804
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20240930_def.xml EX-101.DEF 182405
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20240930_lab.xml EX-101.LAB 532185
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20240930_pre.xml EX-101.PRE 350692
69 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20240930_htm.xml XML 798016
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39567 | Film No.: 241412411
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)